ACAD Historical Earnings image   This ACAD historical earnings page last updated 5/6/2022
ACAD Historical Revenue
PeriodHistorical Earnings DateGAAP
Q1 20225/4/20220.12B
Q4 20212/28/20220.13B
Q3 202111/8/20210.13B
Q2 20218/4/20210.12B
Q1 20215/5/20210.11B
Q4 20202/24/20210.12B
Q3 202011/4/20200.12B
Q2 20208/5/20200.11B
Q1 20205/7/20200.09B
Q4 20192/26/20200.10B
Q3 201910/30/20190.09B
Q2 20197/31/20190.08B
Q1 20195/1/20190.06B
Q4 20182/26/201959.57M
Q3 201811/6/201858.30M
Q2 20188/8/201857.06M
Q1 20185/4/201848.87M
Q4 20172/27/201843.56M
Q3 201711/7/201735.58M
Q2 20178/8/201730.48M
Q1 20175/9/201715.29M
Q4 20162/28/201711.96M
Q3 201611/7/20165.27M
Q2 20168/4/201697000
Q1 20165/5/20164000
Q4 20152/29/201617000
Q3 201511/5/201539000
Q2 20158/6/20151000
Q1 20155/7/20154000
Q4 20142/26/201547000
Q3 201411/10/201415000
Q2 20148/5/201428000
Q1 20145/6/201430000
Q4 20132/27/201437000
Q3 201311/6/2013240000
Q2 20138/6/2013451000
Q1 20135/7/2013417000
Q4 20123/12/2013380000
Q3 201211/5/2012350000
Q2 20128/8/2012599000
Q1 20125/1/2012450000
ACAD Historical Earnings EPS
Data adjusted for ACAD split history

PeriodHistorical Earnings DateGAAP
Q1 20225/4/2022-0.700
Q4 20212/28/2022-0.270
Q3 202111/8/2021-0.090
Q2 20218/4/2021-0.270
Q1 20215/5/2021-0.420
Q4 20202/24/2021-0.420
Q3 202011/4/2020-0.540
Q2 20208/5/2020-0.270
Q1 20205/7/2020-0.570
Q4 20192/26/2020-0.340
Q3 201910/30/2019-0.290
Q2 20197/31/2019-0.380
Q1 20195/1/2019-0.590
Q4 20182/26/2019-0.5
Q3 201811/6/2018-0.5
Q2 20188/8/2018-0.51
Q1 20185/4/2018-0.44
Q4 20172/27/2018-0.55
Q3 201711/7/2017-0.53
Q2 20178/8/2017-0.55
Q1 20175/9/2017-0.72
Q4 20162/28/2017-0.65
Q3 201611/7/2016-0.61
Q2 20168/4/2016-0.63
Q1 20165/5/2016-0.45
Q4 20152/29/2016-0.45
Q3 201511/5/2015-0.39
Q2 20158/6/2015-0.39
Q1 20155/7/2015-0.4
Q4 20142/26/2015-0.28
Q3 201411/10/2014-0.25
Q2 20148/5/2014-0.22
Q1 20145/6/2014-0.19
Q4 20132/27/2014-0.13
Q3 201311/6/2013-0.12
Q2 20138/6/2013-0.11
Q1 20135/7/2013-0.08
Q4 20123/12/2013-0.11
Q3 201211/5/2012-0.04
Q2 20128/8/2012-0.1
Q1 20125/1/2012-0.12
Quotes delayed 20 minutes

Email EnvelopeFree ACAD Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
ACADIA Pharmaceuticals (ACAD) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

ACCD Past Earnings
ACER Past Earnings
ACET Past Earnings
ACHC Past Earnings
ACHV Past Earnings
ACOR Past Earnings
ACRS Past Earnings
ACRX Past Earnings
ADGI Past Earnings
ADIL Past Earnings
What was the record high ACAD historical earnings result?
In terms of earnings or revenue, what is the best ACAD historical earnings result that ACADIA Pharmaceuticals has ever posted, and when?

✔️Accepted answer: Within our data set, the highest ACAD historical earnings result was set in Q3 2012, when ACADIA Pharmaceuticals posted results of -0.04/share. The most successful revenue quarter within our data set was Q3 2021 when ACADIA Pharmaceuticals reported revenue of 0.13B.

What was the lowest ACADIA Pharmaceuticals historical earnings result?
In terms of top line revenue or bottom line earnings per share, what was the lowest ACAD has reported, and when?

✔️Accepted answer: Within our data set, the lowest ACAD historical earnings result was set in Q1 2017, when ACADIA Pharmaceuticals posted results of -0.72/share. The smallest revenue quarter within our data set was Q2 2015 when ACADIA Pharmaceuticals reported revenue of 1000.

On this page we presented the ACAD historical earnings date information for ACADIA Pharmaceuticals. Reviewing that ACAD Historical Earnings for the company, we see that the highest historical earnings result in our data set was in Q3 2012, when ACAD posted gaap of -0.04/share. Meanwhile the lowest ACAD historical earnings result was in Q1 2017, when ACAD posted gaap of -0.72/share. Moving to ACADIA Pharmaceuticalss historical revenue numbers, the largest revenue quarter in our data set was seen in Q3 2021 when ACAD reported 0.13B in revenue, while the smallest revenue quarter was Q2 2015 when ACAD reported 1000 in revenue.

For self directed investors doing their due diligence on ACAD or any other given stock, their research can benefit from looking into all of the ACADIA Pharmaceuticals historical earnings in our data set presented side by side on one page for ease of comparison. Reviewing this historical EPS information can help when projecting future earnings per share, as well as providing important context for pondering whether the historical earnings trajectory justifies the current stock value or not. That's why we bring you HistoricalEarnings.com to make it more convenient for investors to look into ACADIA Pharmaceuticals historical earnings, or the historical earnings information for any stock in our coverage universe. In your continued due diligence investigations, we hope you check out the further links included for historical PE studies, earnings surprises history as well as next earnings dates for ACAD. Thanks for visiting, and the next time you need to research ACAD historical earnings or those of another stock, we hope our site will come to your mind as your preferred historical earnings, revenue, and EPS research resource of choice.

Recommended: RMD Stock Predictions, CLUB Options Chain, WYDE Videos.

 

ACAD Historical Earnings | www.HistoricalEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.